Managing sickle cell disease in children is challenging, due to various factors such as cultural, societal, and parental concerns. These factors often hinder early treatment initiation, despite the well-documented long-term benefits. Medication adherence also poses a significant challenge once treatment has commenced.
Learn MorePolyphotonix wanted to raise awareness of their NHS partnership for the use of their Noctura 400 mask; which utilises green light to treat diabetic retinopathy in those suffering from Diabetes while they sleep. Onyx Health were tasked with gaining national attention for Polyphotonix’s pioneering mask to further opportunities for similar adoption.
Polyphotonix specifically requested national coverage of the partnership, citing The Mail on Sunday and local paper Northern Echo as their key targets.
Learn MoreZilico’s flagship product ZedScan, can identify potential areas of disease in the cervix earlier than traditional colposcopy methods, which have remained relatively unchanged for decades. Messaging needed to be carefully considered so as not to alienate colposcopists by suggesting they were misdiagnosing.
Learn MoreSAFIRA, a tool born from medical device innovation, that improves anaesthetic delivery by regulating the pressure by which anaesthetic is administered for regional anaesthesia, was set to launch in the US. Our client, Medovate, wanted a creative concept and marketing assets to generate interest at a medical congress, but due to COVID-19, the congress was cancelled and we needed to adapt.
Learn MoreThe cardiovascular treatment and prevention pathway is well established, but with relatively little innovation, keeping treatments front of mind was challenging. There is a grey area in current risk reduction guidelines, where clinicians require more guidance when making prescribing decisions.
Learn MoreWe were approached by a global pharma company to help promote their antihistamine product to HCPs. The aim was to communicate the allergy relief benefits for children and adolescents, when compared to competitor products, and drive HCP recommendations
Learn MoreActigen wanted to establish themselves as an expert partner with which to conduct clinical trials in preparation to launch their first clinical trial.
Learn MoreTo increase the availability of a niche drug in European clinical institutions, we work with influential UK and EU chemotherapy nurses to provide a robust education programme, to train nurses and pharmacists in chemotherapy extravasation management.
Learn MoreFollowing a new indication for an oral solution used to treat severe paediatric hypersalivation, Colonis Pharma Limited approached Onyx Health to create a full two-phase launch strategy and a library of materials to accompany the launch.
Learn MoreTo position UL Medicines, a relative newcomer to the unlicensed market, as the go-to company for the supply of all imported unlicensed medicines and specialist products.
Learn More